Kristofor Olson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kristofor Olson has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Jared Rutter
Department of Biochemistry, University of Utah, Salt Lake City, USA
5 shared publications John C. Schell
Department of Biochemistry, University of Utah, Salt Lake City, UT 84132, USA
4 shared publicationsMarc D. Trust
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, USA
3 shared publications- Andreas M. Kaiser
Department of Surgery Division of Colorectal Surgery, City of Hope National Medical Center Duarte California USA
2 shared publications Ben Coopwood
Univ Texas Austin, Dell Med Sch, Dept Surg, Austin, TX 78712 USA
2 shared publicationsCharles E. Hill
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, USA
2 shared publications
Latest Publications
- 29 October 2026
- Published by Wiley in Journal of Surgical Oncology
Retroperitoneal and Lateral Pelvic Lymph Node Dissection for Colorectal Cancer Metastases
Background: Colorectal cancer (CRC) metastases to retroperitoneal (RP) and lateral pelvic (LP) lymph nodes are functionally classified as stage IV disease. While metastasectomy is established for select hepatic and pulmonary metastases, the role of lymphadenectomy for nodal disease remains uncertain. This study evaluates the safety, indications, and oncologic outcomes of RP/LP lymph node dissection in CRC. Methods: A single‐center retrospective review identified patients undergoing RP or LP lymphadenectomy for CRC between 2011 and 2024. Patients with peritoneal metastases or incomplete data were excluded. Demographic, operative, and outcome data were analyzed. Associations with nodal positivity, recurrence‐free survival (RFS), and overall survival (OS) were assessed using Fisher's exact test and univariate Cox regression. Results: Forty‐nine patients underwent lymphadenectomy, 45% for synchronous and 55% for metachronous nodal metastases. Dissection was selective in 61% and formal in 39%, with 86% undergoing concurrent major abdominal procedures. There was no perioperative mortality and dissection‐specific morbidity was low (two lymphatic leaks, both after multivisceral resection). Pathologic nodal metastases were confirmed in 59% of cases. Median RFS and OS were 30.2 and 104.9 months, respectively. Node positivity was associated with initial N2 stage but did not affect RFS or OS. Formal lymphadenectomy was associated with shorter RFS, likely reflecting higher disease burden. Conclusions: RP and LP lymphadenectomy can be safely performed, even with multivisceral resection. Pathologic nodal status did not predict survival, suggesting potential benefit to lymphadenectomy irrespective of final pathology. These findings support its use in carefully selected patients with controlled systemic disease and isolated nodal recurrence.
- 29 October 2026
- Published by Wiley in Journal of Surgical Oncology
Retroperitoneal and Lateral Pelvic Lymph Node Dissection for Colorectal Cancer Metastases
Background: Colorectal cancer (CRC) metastases to retroperitoneal (RP) and lateral pelvic (LP) lymph nodes are functionally classified as stage IV disease. While metastasectomy is established for select hepatic and pulmonary metastases, the role of lymphadenectomy for nodal disease remains uncertain. This study evaluates the safety, indications, and oncologic outcomes of RP/LP lymph node dissection in CRC. Methods: A single‐center retrospective review identified patients undergoing RP or LP lymphadenectomy for CRC between 2011 and 2024. Patients with peritoneal metastases or incomplete data were excluded. Demographic, operative, and outcome data were analyzed. Associations with nodal positivity, recurrence‐free survival (RFS), and overall survival (OS) were assessed using Fisher's exact test and univariate Cox regression. Results: Forty‐nine patients underwent lymphadenectomy, 45% for synchronous and 55% for metachronous nodal metastases. Dissection was selective in 61% and formal in 39%, with 86% undergoing concurrent major abdominal procedures. There was no perioperative mortality and dissection‐specific morbidity was low (two lymphatic leaks, both after multivisceral resection). Pathologic nodal metastases were confirmed in 59% of cases. Median RFS and OS were 30.2 and 104.9 months, respectively. Node positivity was associated with initial N2 stage but did not affect RFS or OS. Formal lymphadenectomy was associated with shorter RFS, likely reflecting higher disease burden. Conclusions: RP and LP lymphadenectomy can be safely performed, even with multivisceral resection. Pathologic nodal status did not predict survival, suggesting potential benefit to lymphadenectomy irrespective of final pathology. These findings support its use in carefully selected patients with controlled systemic disease and isolated nodal recurrence.
- 23 February 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 129 (6) , 1131-1138
Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy
Background and Objectives: Total mesorectal excision (TME) remains the standard of care for patients with rectal cancer who have an incomplete response to total neoadjuvant therapy (TNT). A minority of patients will refuse curative intent resection. The aim of this study is to examine the outcomes for these patients.Methods: A retrospective cohort study of stage 1−3 rectal adenocarcinoma patients who underwent neoadjuvant chemoradiation therapy or TNT at a single institution. Patients either underwent TME, watch‐and‐wait protocol, or if they refused TME, were counseled and watched (RCW). Clinical outcomes and resource utilization were examined in each group.Results: One hundred seventy‐one patients (Male 59%) were included with a median surveillance of 43 months. Twenty‐nine patients (17%) refused TME and had shortened overall survival (OS). Twelve patients who refused TME converted to a complete clinical response (cCR) on subsequent staging with a prolonged OS. 92% of these patients had a near cCR at initial staging endoscopy. Increased physician visits and testing was utilized in RCW and WW groups.Conclusion: A significant portion of patients convert to cCR and have prolonged OS. Lengthening the time to declare cCR may be considered in select patients, such as those with a near cCR at initial endoscopic staging.
- 23 February 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 129 (6) , 1131-1138
Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy
Background and Objectives: Total mesorectal excision (TME) remains the standard of care for patients with rectal cancer who have an incomplete response to total neoadjuvant therapy (TNT). A minority of patients will refuse curative intent resection. The aim of this study is to examine the outcomes for these patients.Methods: A retrospective cohort study of stage 1−3 rectal adenocarcinoma patients who underwent neoadjuvant chemoradiation therapy or TNT at a single institution. Patients either underwent TME, watch‐and‐wait protocol, or if they refused TME, were counseled and watched (RCW). Clinical outcomes and resource utilization were examined in each group.Results: One hundred seventy‐one patients (Male 59%) were included with a median surveillance of 43 months. Twenty‐nine patients (17%) refused TME and had shortened overall survival (OS). Twelve patients who refused TME converted to a complete clinical response (cCR) on subsequent staging with a prolonged OS. 92% of these patients had a near cCR at initial staging endoscopy. Increased physician visits and testing was utilized in RCW and WW groups.Conclusion: A significant portion of patients convert to cCR and have prolonged OS. Lengthening the time to declare cCR may be considered in select patients, such as those with a near cCR at initial endoscopic staging.
- 8 April 2023
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 49 (5) , 2173-2176
Rule of four: an anatomic and value-based approach to stent-graft inventory for blunt thoracic aortic injury
Purpose As blunt thoracic aortic injury (BTAI) treatment has shifted from open to thoracic endovascular aortic repair (TEVAR), logistical challenges exist in creating and maintaining inventories of appropriately sized stent-grafts, including storage demands, shelf-life management and cost. We hypothesized that most injured aortas can be successfully repaired with a narrow range of stent-graft sizes and present a value-based anatomic approach to optimizing inventory. Methods CT-scans of all patients with BTAI admitted to our Level I trauma center from Apr 2010-Dec 2018 were reviewed. Patients with anatomy incompatible with TEVAR were excluded. For each patient, after aortic sizing a set of two stent-grafts most likely to be utilized was selected from a list of twenty commercially available GORE conformable TAG endografts based on manufacturer instructions. Stent-graft sizes were then ranked based on the number of cases they would be suitable for. MATLAB was utilized to determine the combinations of stent-grafts which would cover the most patients. Results Twenty-eight patients with BTAI were identified and three were excluded based on iliac diameter. Most patients were male (68%), mean age 42.3 ± 20.2 years, mean ISS 37.0 ± 9.8. Overall mortality was 25%. Of the 20 available stent-graft options, a combination of four stent-grafts would successfully treat 100% of the patients in this series. Conclusions Based on actual CT-scan aortic measurements, we demonstrated that an inventory of four sent-graft sizes was sufficient to treat 100% of patients with BTAI. These data can be utilized as a value-based anatomic approach to aortic stent-graft institutional inventory creation and maintenance.
- 8 April 2023
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 49 (5) , 2173-2176
Rule of four: an anatomic and value-based approach to stent-graft inventory for blunt thoracic aortic injury
Purpose As blunt thoracic aortic injury (BTAI) treatment has shifted from open to thoracic endovascular aortic repair (TEVAR), logistical challenges exist in creating and maintaining inventories of appropriately sized stent-grafts, including storage demands, shelf-life management and cost. We hypothesized that most injured aortas can be successfully repaired with a narrow range of stent-graft sizes and present a value-based anatomic approach to optimizing inventory. Methods CT-scans of all patients with BTAI admitted to our Level I trauma center from Apr 2010-Dec 2018 were reviewed. Patients with anatomy incompatible with TEVAR were excluded. For each patient, after aortic sizing a set of two stent-grafts most likely to be utilized was selected from a list of twenty commercially available GORE conformable TAG endografts based on manufacturer instructions. Stent-graft sizes were then ranked based on the number of cases they would be suitable for. MATLAB was utilized to determine the combinations of stent-grafts which would cover the most patients. Results Twenty-eight patients with BTAI were identified and three were excluded based on iliac diameter. Most patients were male (68%), mean age 42.3 ± 20.2 years, mean ISS 37.0 ± 9.8. Overall mortality was 25%. Of the 20 available stent-graft options, a combination of four stent-grafts would successfully treat 100% of the patients in this series. Conclusions Based on actual CT-scan aortic measurements, we demonstrated that an inventory of four sent-graft sizes was sufficient to treat 100% of patients with BTAI. These data can be utilized as a value-based anatomic approach to aortic stent-graft institutional inventory creation and maintenance.
- 5 December 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 283, 778-782
If at First You Do Not Succeed: Consideration of Attempts in Patients With Trauma
- 5 December 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 283, 778-782
If at First You Do Not Succeed: Consideration of Attempts in Patients With Trauma
- 10 September 2020
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 383 (11) , 1081-1083
Penetrating Injuries from “Less Lethal” Beanbag Munitions
In the spring of 2020, after the death of George Floyd in police custody, protests against racial injustice and police brutality broke out across the country. In Austin, Texas, tensions culminated in 2 days of vigorous protest, during which police used beanbag munitions for crowd control, resulting in numerous clinically significant injuries. The literature regarding injuries from beanbag munitions is scarce, with previous reports describing predominantly minor blunt-injury patterns with limited penetrating thoracic, ocular, and facial trauma.1-4
- 10 September 2020
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 383 (11) , 1081-1083
Penetrating Injuries from “Less Lethal” Beanbag Munitions
In the spring of 2020, after the death of George Floyd in police custody, protests against racial injustice and police brutality broke out across the country. In Austin, Texas, tensions culminated in 2 days of vigorous protest, during which police used beanbag munitions for crowd control, resulting in numerous clinically significant injuries. The literature regarding injuries from beanbag munitions is scarce, with previous reports describing predominantly minor blunt-injury patterns with limited penetrating thoracic, ocular, and facial trauma.1-4
- 1 July 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 72 (1) , e254-e255
Rule of Four: A Value-Based Approach to Aortic Stent Graft Inventory Creation for the Treatment of Blunt Thoracic Aortic Injuries Using Real Patient Aortic Measurements
- 1 July 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 72 (1) , e254-e255
Rule of Four: A Value-Based Approach to Aortic Stent Graft Inventory Creation for the Treatment of Blunt Thoracic Aortic Injuries Using Real Patient Aortic Measurements
- 1 February 2020
- Published by Elsevier in Cell Metabolism
- Vol. 31 (2) , 284-300.e7
Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
- 1 February 2020
- Published by Elsevier in Cell Metabolism
- Vol. 31 (2) , 284-300.e7
Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
- 24 September 2018
- Published by Wiley in The Breast Journal
- Vol. 24 (6) , 1055-1061
Secretory breast carcinoma in an 8-year-old girl: A case report and literature review
Secretory breast carcinoma (SBC) is a rare form of breast cancer found in both children and adults, and is the most common breast cancer in the pediatric population. Although SBC usually carries a favorable prognosis, there have been reported cases of axillary and distant metastases. Surgery is the primary mode of treatment, however, there exists variability within the literature surrounding the management of SBC. We report a case of an 8‐year‐old girl who presented with a firm, mobile, palpable breast mass. Ultrasonography was performed, followed by local excision, with surgical pathology concerning for SBC. The patient was definitively treated with mastectomy and sentinel lymph node (SLN) biopsy. She received no adjuvant therapies and 2 years later, remains disease free. Herein, we review the literature, curate data from 89 reported cases of pediatric and adult SBC, and address some of the controversy surrounding its treatment. From this review we conclude that patients with SBC should be reviewed at multidisciplinary treatment planning conference, undergo surgery with mastectomy or lumpectomy with SLN biopsy, and have long‐term postoperative follow‐up.
- 24 September 2018
- Published by Wiley in The Breast Journal
- Vol. 24 (6) , 1055-1061
Secretory breast carcinoma in an 8-year-old girl: A case report and literature review
Secretory breast carcinoma (SBC) is a rare form of breast cancer found in both children and adults, and is the most common breast cancer in the pediatric population. Although SBC usually carries a favorable prognosis, there have been reported cases of axillary and distant metastases. Surgery is the primary mode of treatment, however, there exists variability within the literature surrounding the management of SBC. We report a case of an 8‐year‐old girl who presented with a firm, mobile, palpable breast mass. Ultrasonography was performed, followed by local excision, with surgical pathology concerning for SBC. The patient was definitively treated with mastectomy and sentinel lymph node (SLN) biopsy. She received no adjuvant therapies and 2 years later, remains disease free. Herein, we review the literature, curate data from 89 reported cases of pediatric and adult SBC, and address some of the controversy surrounding its treatment. From this review we conclude that patients with SBC should be reviewed at multidisciplinary treatment planning conference, undergo surgery with mastectomy or lumpectomy with SLN biopsy, and have long‐term postoperative follow‐up.
- 16 October 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (3) , 417-424
Provider views on the management of Ewing sarcoma of the spine and pelvis
Background: Curative therapy for ES requires both chemotherapy and local control of primary tumor. There is no universally accepted standard approach to local control modalities. This survey was conducted to determine practice patterns and factors influencing the choice to offer various local control modalities to patients with ES of the spine and pelvis.Methods: The survey consisted of four scenarios involving a 15‐year‐old girl who presented with Ewing sarcoma of thoracic vertebra, sacrum, iliac wing, and acetabulum with or without neurologic compromise. The questionnaire was sent to oncologists, orthopedic surgeons, and radiation oncologists, asking their recommendations for local control modality.Results: Among 94 respondents, radiotherapy was most frequently chosen for sacral tumors (68.1%) and T10 vertebral tumors (46.2%) whereas surgery was preferred for iliac wing pelvic tumors (45.7%) and acetabular tumors (43.6%). Orthopedic surgeons were significantly more likely to offer surgery than radiation oncologists (OR 3.07, 95%CI 1.37‐6.88, P = 0.007). Providers outside North America were more likely to offer combined surgery plus radiotherapy (OR 10.58, 95%CI 5.41‐20.70, P < 0.001).Conclusion: Considerable heterogeneity exists in local control modalities for Ewing sarcoma of the spine and pelvis. Specialty and location of practice may influence treatment recommendations.
- 16 October 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (3) , 417-424
Provider views on the management of Ewing sarcoma of the spine and pelvis
Background: Curative therapy for ES requires both chemotherapy and local control of primary tumor. There is no universally accepted standard approach to local control modalities. This survey was conducted to determine practice patterns and factors influencing the choice to offer various local control modalities to patients with ES of the spine and pelvis.Methods: The survey consisted of four scenarios involving a 15‐year‐old girl who presented with Ewing sarcoma of thoracic vertebra, sacrum, iliac wing, and acetabulum with or without neurologic compromise. The questionnaire was sent to oncologists, orthopedic surgeons, and radiation oncologists, asking their recommendations for local control modality.Results: Among 94 respondents, radiotherapy was most frequently chosen for sacral tumors (68.1%) and T10 vertebral tumors (46.2%) whereas surgery was preferred for iliac wing pelvic tumors (45.7%) and acetabular tumors (43.6%). Orthopedic surgeons were significantly more likely to offer surgery than radiation oncologists (OR 3.07, 95%CI 1.37‐6.88, P = 0.007). Providers outside North America were more likely to offer combined surgery plus radiotherapy (OR 10.58, 95%CI 5.41‐20.70, P < 0.001).Conclusion: Considerable heterogeneity exists in local control modalities for Ewing sarcoma of the spine and pelvis. Specialty and location of practice may influence treatment recommendations.